Back to Search
SCOTT CULP, D.O.
D.O.
Family Medicine Physician
NPI: 1861482275IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
OS010102L(PA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1997
Research & Publications (20)
The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
PMID 19522868·BJU Int·2009
8-other
Should patients undergoing surgery for renal cell carcinoma have a lymph node dissection?
PMID 19204738·Nat Clin Pract Urol·2009
8-other
DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
PMID 10874023·Carcinogenesis·2000
7-preclinical
Words of wisdom. Re: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomized, placebo- controlled phase III trial.
PMID 19650216·Eur Urol·2009
8-other
Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
PMID 18343432·J Urol·2008
8-other
Carcinogenicity of malachite green chloride and leucomalachite green in B6C3F1 mice and F344 rats.
PMID 16554117·Food Chem Toxicol·2006
7-preclinical
High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
PMID 16097804·Chem Res Toxicol·2005
7-preclinical
Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
PMID 16054776·Cancer Detect Prev·2005
4-observational
Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells.
PMID 15120962·Mutat Res·2004
8-other
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
PMID 15368471·Prostate·2004
7-preclinical
NTP technical report on the toxicity studies of malachite green chloride and leucomalachite green (CAS Nos. 569-64-2 and 129-73-7) administered in feed to F344/N rats and B6C3F1 mice.
PMID 15213768·Toxic Rep Ser·2004
7-preclinical
Analysis of mutations and bone marrow micronuclei in Big Blue rats fed leucomalachite green.
PMID 15013694·Mutat Res·2004
4-observational
Photoreaction, phototoxicity, and photocarcinogenicity of retinoids.
PMID 15845224·J Environ Sci Health C Environ Carcinog Ecotoxicol Rev·2003
6-review
Synthesis and characterization of N-demethylated metabolites of malachite green and leucomalachite green.
PMID 12641428·Chem Res Toxicol·2003
8-other
The effect of deuterium and fluorine substitution upon the mutagenicity of N-hydroxy-2,6-dimethylaniline.
PMID 12351143·Mutat Res·2002
4-observational
Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression.
PMID 12082015·Carcinogenesis·2002
7-preclinical
Characterization of DNA adducts derived from syn-benzo[ghi]fluoranthene-3,4-dihydrodiol-5,5a-epoxide and comparative DNA binding studies with structurally-related anti-diolepoxides of benzo[ghi]fluoranthene and benzo[c]phenanthrene.
PMID 11849046·Chem Res Toxicol·2002
4-observational
DNA adducts from nitroreduction of 2,7-dinitrofluorene, a mammary gland carcinogen, catalyzed by rat liver or mammary gland cytosol.
PMID 11952340·Chem Res Toxicol·2002
7-preclinical
Mutagenicity and carcinogenicity in relation to DNA adduct formation in rats fed leucomalachite green.
PMID 12351145·Mutat Res·2002
4-observational
Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19.
PMID 11319802·Genes Chromosomes Cancer·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 725 SKIPPACK PIKE, PAREC PLAZA 2ND FLOOR
BLUE BELL, PA 19422 - Phone
- (215) 542-1300
Quick Facts
- NPI
- 1861482275
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile